History : Trustees : Steering Committee : HINJ Staff
|
|
Greg Arnsdorff
President
Abbott Point of Care, Inc.
Akrimax Pharmaceuticals, LLC
John F. Crowley
President & CEO
Amicus Therapeutics, Inc.
Philip Gioia
Head of North American Pharma and Global Gen.
Bausch + Lomb
Robert T. Davis, Jr.
General Manager
Baxter Healthcare Corporation
Dan Apel
Senior Vice President
Bayer HealthCare
Jeffrey S. Sherman
Senior Vice President and General Counsel
BD
Giovanni Caforio, MD
President, US Pharmaceuticals
Bristol-Myers Squibb
Timothy M. Ring (Chairman)
Chairman and Chief Executive Officer
C. R. Bard, Inc.
John Chiminski
President and Chief Executive Officer
Catalent Pharma Solutions
Robert J. Hugin (Immediate Past Chairman)
Chief Executive Officer
Celgene Corporation
Craig B. Bleifer
Vice President and General Counsel
Daiichi Sankyo, Inc.
Chris Lockett
Senior Director of Government Affairs
Dendreon Corporation
David Trexler
Vice President, U.S. Marketing
Eisai Inc. of North America
Caroline B. Manogue
Executive Vice President, Chief Legal Officer and Secretary
Endo Pharmaceuticals
Marco Taglietti, M.D.
President
Forest Research Institute, Inc.
Evan Morris
Vice President, Government Affairs & Public Policy
Genentech, Inc.
John F. Del Giorno
Vice President, Government Relations
GlaxoSmithKline
Bernhard Ehmer, M.D.
President
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
Cynthia L. Sullivan, M.S., M.B.A.
President and Chief Executive Officer
Immunomedics, Inc.
Clifford E. Holland (Vice Chairman, Medical Technology)
Corporate Vice President, Government Affairs & Policy
Johnson & Johnson
Stevin Zorn
Executive Vice President, Research and Development
Lundbeck Research USA
Willie A. Deese
Executive Vice President & President, Merck Manufacturing Division
Merck & Co., Inc.
Thomas J. Fussaro
Associate Director, Federal and Government Relations and Public Policy
Millennium, The Takeda Oncology Company
Alan L. Rubino
President and Chief Executive Officer
New American Therapeutics, Inc.
Kevin T. Rigby (Vice Chairman, Pharmaceuticals)
Vice President, Public Affairs & Communications
Novartis Pharmaceuticals Corporation
James C. Shehan
Vice President & General Counsel, Legal, Government and Quality Affairs
Novo Nordisk Pharmaceuticals, Inc.
Edward H. Stratemeier
Senior Vice President and General Counsel, Legal Affairs, Corporate Secretary
NPS Pharmaceuticals
Cavan M. Redmond
Senior Vice President and Group President, Pfizer Diversified Businesses
Pfizer Inc.
Anne Whitaker
President, North America
Sanofi
Yin Becker
Vice President, Health Care Innovations
Stryker Corporation
|
